Performance
Day's Low
Day's High
₹138.35₹146.4852 Week's Low
52 Week's High
₹74.15₹169
| Returns % | |
| 1 Month Return | -5.08 % |
| 3 Month Return | + 41.65 % |
| 1 Year Return | + 79.56 % |
| Market Stats | |
| Previous Close | ₹143.65 |
| Open | ₹145.10 |
| Volume | 11.70L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹3,688.67Cr |
Key Statistics
| P/E Ratio | 13.18 |
| PEG Ratio | 12.92 |
| Market Cap | ₹3,688.67 Cr |
| P/B Ratio | 2.66 |
| EPS | 3.62 |
| Dividend Yield | 2.87 |
| Sector | Realty |
| ROE | 11.34 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹3,688.67 Cr | 36.72% | 0.51 | ₹92 Cr | ₹157 Cr | |
| HOLD | ₹18,921.93 Cr | 54.02% | 0.72 | ₹49 Cr | ₹3,096 Cr | |
| NA | ₹2,240.20 Cr | 349.97% | 0.63 | -₹76 Cr | ₹257 Cr | |
| HOLD | ₹8,019.75 Cr | 57.23% | 0.61 | ₹374 Cr | ₹3,855 Cr | |
| NA | ₹500.97 Cr | 1.77% | 0.67 | ₹233 Cr | ₹206 Cr |
Company Information
Share Price: ₹139.83 per share as on 19 Sep, 2024 04:01 PM
Market Capitalisation: ₹3,688.67Cr as of today
Revenue: ₹50.78Cr as on June 2024 (Q2 24)
Net Profit: ₹17.42Cr as on June 2024 (Q2 24)
Listing date: 04 Jan, 1995
Chairperson Name: Chirayu R Amin
| Organisation | Alembic Ltd |
| Headquarters | Vadodara |
| Industry | Realty |
| E-voting on shares | Click here to vote |
Key events for Alembic Ltd
Alembic Pharmaceuticals Gains USFDA Approval for Generic Drug - 27 Aug, 2024
Alembic Pharmaceuticals has received USFDA approval for its generic Betamethasone Valerate Foam, which is therapeutically equivalent to Luxiq Foam, for treating moderate-to-severe psoriasis of the scalp.
Alembic Pharmaceuticals Secures USFDA Approval - 26 Aug, 2024
Alembic Pharmaceuticals has received final USFDA approval for its Abbreviated New Drug Application for Betamethasone Valerate foam, which treats scalp skin conditions.
Alembic Ltd Faces Downgrade Amid Q1 Sales Miss - 12 Aug, 2024
Alembic Ltd has been downgraded to 'Reduce' with a target price of Rs 1,080 per share following a Q1 earnings miss. While US sales were in line, other segments fell short of estimates. The current stock price reflects overly optimistic expectations for US sales growth, although higher sales from new launches present an upside risk.
Insights on Alembic Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 41.55 Cr → 52.74 Cr (in ₹), with an average increase of 10.9% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.07% to 1.42% in Jun 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ALEMBICLTD has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 70.88% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 119.4%
NEGATIVE IMPACTPrice Dip
In the last 7 days, ALEMBICLTD stock has moved down by -7.6%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 72.15 Cr → 55.82 Cr (in ₹), with an average decrease of 22.6% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 28.00% to 27.64% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 70.88% | 0.00 | |
| Foreign Institutions | 1.42% | 33.51 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 27.64% | ||
| Others | 0.05% | 0.00 |
Key Indicators
Alembic Ltd Valuation
Alembic Ltd in the last 5 years
Lowest (2.82x)
March 31, 2020
Today (13.18x)
September 18, 2024
Industry (178.36x)
September 18, 2024
Highest (15.06x)
August 23, 2024
Earnings and Dividends
Alembic Ltd Earnings Results
Alembic Ltd’s net profit jumped 25.78% since last year same period to ₹55.82Cr in the Q1 2024-2025. On a quarterly growth basis, Alembic Ltd has generated -22.63% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlembic Ltd Dividends May,2024
In the quarter ending March 2024, Alembic Ltd has declared dividend of ₹2.40 - translating a dividend yield of 1.67%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Alembic Ltd is currently in a Bearish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Alembic Ltd shares.
Alembic Ltd (ALEMBICLTD) share price today is ₹139.83
Alembic Ltd is listed on NSE
Alembic Ltd is listed on BSE
- Today’s highest price of Alembic Ltd is ₹146.48.
- Today’s lowest price of Alembic Ltd is ₹138.35.
PE Ratio of Alembic Ltd is 13.18
PE ratio = Alembic Ltd Market price per share / Alembic Ltd Earnings per share
Today’s traded volume of Alembic Ltd(ALEMBICLTD) is 11.70L.
Today’s market capitalisation of Alembic Ltd(ALEMBICLTD) is ₹3688.67Cr.
| Alembic Ltd(ALEMBICLTD | Price |
|---|---|
52 Week High | ₹169 |
52 Week Low | ₹74.15 |
Alembic Ltd(ALEMBICLTD) share price is ₹139.83. It is down -17.26% from its 52 Week High price of ₹169
Alembic Ltd(ALEMBICLTD) share price is ₹139.83. It is up 88.58% from its 52 Week Low price of ₹74.15
| Alembic Ltd(ALEMBICLTD | Returns |
|---|---|
1 Day Returns | -3.82% |
1 Month Returns | -5.08% |
3 Month Returns | 41.65% |
1 Year Returns | 79.56% |